Magdalena Tertil

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index770citations44works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(25), Angiogenesis and VEGF in Cancer(16), Stress Responses and Cortisol(8), Cancer, Lipids, and Metabolism(7), Neuroendocrine regulation and behavior(6)

Publications44 total

Supplementary Figure 1 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 3 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 3 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 6 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Data from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Data from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Materials and Methods and Supplementary Figure Legends from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 1 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 6 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 5 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Materials and Methods and Supplementary Figure Legends from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 4 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 2 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 5 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 2 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Supplementary Figure 4 from Hypoxia-Regulated Overexpression of Soluble VEGFR2 Controls Angiogenesis and Inhibits Tumor Growth
2023Open Access
Astroglial Knockout of Glucocorticoid Receptor Attenuates Morphine Withdrawal Symptoms, but Not Antinociception and Tolerance in Mice
Cellular and Molecular Neurobiology·2021· 3 citedOpen Access
Knockdown of the astrocytic glucocorticoid receptor in the central nucleus of the amygdala diminishes conditioned fear expression and anxiety
Behavioural Brain Research·2021· 21 cited
Astrocytes determine conditioned response to morphine via glucocorticoid receptor-dependent regulation of lactate release
Neuropsychopharmacology·2019· 37 citedOpen Access
Glucocorticoid receptor signaling in astrocytes is required for aversive memory formation
Translational Psychiatry·2018· 69 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Józef Dulak(27), Alicja Józkowicz(26), Claudine Kiéda(23), Guillaume Collet(20), Alan Guichard(20), Jacek Stępniewski(19), Nathalie Lamerant‐Fayel(18), Bouchra El Hafny‐Rahbi(17), Alexandra Foucault‐Collet(17), Krzysztof Klimkiewicz(17), Stéphane Pètoud(17), Agata Matejuk(17), Catherine Grillon(17), Sławomir Gołda(12), Urszula Skupio(11), Ryszard Przewłocki(11), Lucja Kudla(8), Justyna Barut(7), Klaudia Skrzypek(6), Agnieszka Łoboda(6)